Influenza Clinical Trials

A listing of Influenza medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 61 clinical trials
Featured trial
Novavax S1865

Get the Novavax vaccine or booster and take a survey to qualify for $175.00 in compensation. Novavax uses the traditional vaccine technology that has been used for years for influenza (flu

Accepts healthy volunteers
  • 14 views
  • 29 Sep, 2022
  • 2 locations
A PHASE 1/2 RANDOMIZED STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A MODIFIED RNA VACCINE AGAINST INFLUENZA IN HEALTHY INDIVIDUALS

monovalent influenza modRNA vaccine (mIRV) and bivalent influenza modRNA vaccine (bIRV) at various dose levels, and quadrivalent influenza modRNA vaccine (qIRV), in participants 65 to 85 years of age

Accepts healthy volunteers
vaccination
quadrivalent inactivated influenza vaccine
strain
trivalent influenza vaccine
  • 18 views
  • 22 Sep, 2022
  • 82 locations
Seasonal Influenza Vaccine Uptake Among Health Care Workers Following Awareness and Availability of Influenza Vaccine Supply in Tertiary Care Hospitals, Bangladesh

influenza virus infections. HCWs may also transmit and spread influenza among hospitalized patients and other caregivers. HCWs often (40-83%) work while experiencing influenza-like illness (ILI

  • 0 views
  • 20 Sep, 2022
  • 1 location
An Open Phase I and Randomized, Double-blind, Controlled Phase III Clinical Trial to Evaluate the Safety and Immunogenicity of Quadrivalent Influenza Vaccine in Healthy Subjects Aged 6 to 35months.

The study of quadrivalent influenza vaccine manufactured by Sinovac Biotech Co., Ltd will conduct in two phases,the phaseⅠclinical trial of the study will be open-label design,and the phase III

Accepts healthy volunteers
  • 0 views
  • 17 Sep, 2022
A Phase 3, Randomized, Stratified, Observer-blind, Active-Controlled Study to Evaluate the Immunogenicity and Safety of mRNA-1010 Seasonal Influenza Vaccine in Adults 18 Years and Older

The primary objectives of this study are to evaluate the humoral immunogenicity of mRNA-1010 relative to that of an active comparator against vaccine-matched influenza A and B strains at Day 29

Accepts healthy volunteers
  • 0 views
  • 16 Sep, 2022
  • 26 locations
A Phase Ⅲ, Randomized, Double-blind and Controlled Clinical Trial to Evaluate the Immunogenicity and Safety of Influenza Vaccine (Split Virion), Inactivated, Quadrivalent in Individuals Aged 3 Years and Older in Chile

The purpose of this study is to evaluate the safety and immunogenicity of Influenza vaccine (Split virion), Inactivated, Quadrivalent developed by Sinovac Biotech Co., Ltd. (Sinovac-QIV) as

Accepts healthy volunteers
  • 0 views
  • 19 Sep, 2022
  • 2 locations
Safety and Immunogenicity of GSK Meningococcal Group B Vaccine and 13-valent Pneumococcal Vaccine Administered Concomitantly With Routine Infant Vaccines to Healthy Infants

The purpose of this study is to evaluate the safety and immunogenicity of Bexsero (meningococcal group B vaccine-rMenB+OMV NZ) in North American infants 6 weeks through 12 weeks of age, when administered concomitantly with Pneumococcal conjugate vaccine (PCV 13) and other recommended routine infant vaccines(RIV).

conjugate vaccine
hiberix
pneumococcal
vaccination
varivax
  • 268 views
  • 17 Sep, 2022
  • 31 locations
Clinical Trial of Quadrivalent Influenza Virus Split Vaccine in Population Aged 3-8 Years

To evaluate the safety and immunogenicity of quadrivalent influenza virus split vaccine in healthy population aged 3-8 years following different immunization procedures.

vaccination
quadrivalent inactivated influenza vaccine
strain
trivalent influenza vaccine
Accepts healthy volunteers
  • 0 views
  • 10 Aug, 2022
  • 1 location
  • 0 views
  • 18 Sep, 2022
  • 2 locations
A PHASE 1, PLACEBO-CONTROLLED, RANDOMIZED, OBSERVER-BLIND, DOSE-FINDING STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF SELF-AMPLIFYING RNA VACCINE PREPARATIONS AGAINST INFLUENZA IN HEALTHY INDIVIDUALS

This is a dose-finding study to evaluate the safety, tolerability, and immunogenicity of self- amplifying ribonucleic acid (saRNA) vaccine preparations against influenza in healthy adults 18

Accepts healthy volunteers
trivalent influenza vaccine
quadrivalent inactivated influenza vaccine
  • 15 views
  • 20 Sep, 2022
  • 23 locations